CSL Receives Bird Flu Vaccine Contract

This is a news story, published by Yahoo, that relates primarily to the U.S. Department of Health and Human Services news.

News about vaccine development

For more vaccine development news, you can click here:

more vaccine development news

Yahoo news

For more news from Yahoo, you can click here:

more news from Yahoo

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about

bird flu vaccines

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest bird flu outbreak news, bird flu news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

bird flu vaccine

Reuters

•

CSL gets $121 million contract to increase US stockpile for bird flu vaccines to 40 million doses

Summary

Nutrition label

81% Informative

CSL says it has got a contract from the U.S. Department of Health and Human Services worth $121.4 million .

Under the multi-year contract CSL will deliver its MF59 adjuvant, an ingredient that can be used to manufacture vaccines against the H5 avian influenza virus.

H5 bird flu is widespread in wild birds worldwide and is causing outbreaks in poultry.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech